These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27002763)

  • 1. Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer.
    Fahrmann JF; Grapov D; DeFelice BC; Taylor S; Kim K; Kelly K; Wikoff WR; Pass H; Rom WN; Fiehn O; Miyamoto S
    Cancer Biomark; 2016 Mar; 16(4):609-17. PubMed ID: 27002763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers.
    Shen J; Liu Z; Todd NW; Zhang H; Liao J; Yu L; Guarnera MA; Li R; Cai L; Zhan M; Jiang F
    BMC Cancer; 2011 Aug; 11():374. PubMed ID: 21864403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive plasma metabolomics and lipidomics of benign and malignant solitary pulmonary nodules.
    Zhou W; Lin L; Jiang LY; Wu JL; Xu WC; Zhou Y; Wang MJ; Cao XM; Lin HQ; Yang J; Deng LC; Zhang ZH; Shan JJ
    Metabolomics; 2022 Aug; 18(9):71. PubMed ID: 36036299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.
    Xing L; Su J; Guarnera MA; Zhang H; Cai L; Zhou R; Stass SA; Jiang F
    Clin Cancer Res; 2015 Jan; 21(2):484-9. PubMed ID: 25593345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
    Li X; Zhang Q; Jin X; Cao L
    World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of Combined Detection of Cytokines and Tumor Markers in the 
Differential Diagnosis of Benign and Malignant Solitary Pulmonary Nodules].
    Shi J; Liu X; Ming Z; Li W; Lv X; Yang X; Wang Y; Zhang M; Yang S
    Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):426-433. PubMed ID: 34157802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.
    Zheng J; Ye X; Liu Y; Zhao Y; He M; Xiao H
    BMC Cancer; 2020 Feb; 20(1):106. PubMed ID: 32041568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic enhancement patterns of solitary pulmonary nodules at multi-detector row CT and correlation with vascular endothelial growth factor and microvessel density.
    Jiang NC; Han P; Zhou CK; Zheng JL; Shi HS; Xiao J
    Ai Zheng; 2009 Feb; 28(2):164-9. PubMed ID: 19550130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation study between dual source CT perfusion imaging and the microvascular composition of solitary pulmonary nodules.
    Wang M; Li B; Sun H; Huang T; Zhang X; Jin K; Wang F; Luo X
    Lung Cancer; 2019 Apr; 130():115-120. PubMed ID: 30885331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
    Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
    J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of malignant and benign pulmonary nodules with first-pass dual-input perfusion CT.
    Yuan X; Zhang J; Quan C; Cao J; Ao G; Tian Y; Li H
    Eur Radiol; 2013 Sep; 23(9):2469-74. PubMed ID: 23793548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural network-based computer-aided diagnosis in distinguishing malignant from benign solitary pulmonary nodules by computed tomography.
    Chen H; Wang XH; Ma DQ; Ma BR
    Chin Med J (Engl); 2007 Jul; 120(14):1211-5. PubMed ID: 17697569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased levels of circulating sex hormones as a biomarker of lung cancer in male patients with solitary pulmonary nodules.
    Gu T; Wen Z; Xu S; Hua H; Zhang Z; Wen T; Fu Z; Lv X
    Afr Health Sci; 2014 Jun; 14(2):356-63. PubMed ID: 25320584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma.
    Codreanu SG; Hoeksema MD; Slebos RJC; Zimmerman LJ; Rahman SMJ; Li M; Chen SC; Chen H; Eisenberg R; Liebler DC; Massion PP
    J Proteome Res; 2017 Sep; 16(9):3266-3276. PubMed ID: 28731711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
    Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
    Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
    J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical-radiological predictive model in differential diagnosis of small (≤ 20 mm) solitary pulmonary nodules.
    Zhao HC; Xu QS; Shi YB; Ma XJ
    BMC Pulm Med; 2021 Sep; 21(1):281. PubMed ID: 34482833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitary pulmonary nodules: comparison of multi-slice computed tomography perfusion study with vascular endothelial growth factor and microvessel density.
    Bai RJ; Cheng XG; Qu H; Shen BZ; Han MJ; Wu ZH
    Chin Med J (Engl); 2009 Mar; 122(5):541-7. PubMed ID: 19323905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and work-up of small to intermediate-sized pulmonary nodules in a Chinese dedicated cancer hospital.
    Cui X; Han D; Heuvelmans MA; Du Y; Zhao Y; Zhang L; Groen HJM; de Bock GH; Dorrius MD; Oudkerk M; Vliegenthart R; Ye Z
    Cancer Biol Med; 2020 Feb; 17(1):199-207. PubMed ID: 32296586
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of circulating rare cells benefitted the diagnosis of malignant solitary pulmonary nodules.
    Xie J; Ruan Z; Zheng J; Gong Y; Wang Y; Hu B; Cheng J; Huang Q
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2681-2692. PubMed ID: 34791530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.